WSC Spotlight: Maternal and Neonatal Sepsis

wsc spotlight maternal neonatal sepsis

A Free Online Congress by WHO and GSA

The Global Sepsis Alliance (GSA) and the World Health Organization (WHO) have joined forces to host the WSC Spotlight: Maternal and Neonatal Sepsis on September 12, 2017.

The WSC Spotlight is a free online congress that follows in the footsteps of the 1st World Sepsis Congress 2016. It focuses on a main topic, which in 2017 is Maternal and Neonatal Sepsis. During 4 distinctive sessions, over 20 international speakers will share their knowledge and give updates on maternal and neonatal sepsis in 10-minute presentations and keynotes. After each talk, the speakers will answer live questions from the audience. All presentations will be made available to view on demand on the World Sepsis Congress YouTube Channel and as a Podcast on Apple Podcasts after the event.

Do use this great opportunity to connect to and learn from leading sepsis experts from around the globe – just register and login from wherever you are. Find out more on registration, program, speakers, time zones etc. on www.wscspotlight.org.

There are two presentations on the importance of biomarkers in antibiotic stewardship that we recommend to you especially:

  • Session 3 / Neonatal Sepsis: 17:45 UTC
    Is There a Role for Biomarkers in Antibiotic Stewardship in Neonates Suspected of Early Onset Sepsis?
    Annemarie van Rossum, Erasmus MC University Medical Center Rotterdam - Sophia Children’s Hospital, Netherlands
  • Session 4 / Updates on Sepsis: 19:15h UTC
    The Potential of Biomarkers for Antibiotic Stewardship
    Phillip Schuetz, Cantonal Hospital Aarau, Switzerland

Read more about biomarkers in antibiotic stewardship:

Van Rossum AM et al., Lancet Infect Dis 2004;4 (10),Oct: 620-30: Procalcitonin as an early marker of infection in neonates and children; http://dx.doi.org/10.1016/S1473-3099(04)01146-6

Stocker M et al., Lancet 2017, Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns); http://dx.doi.org/10.1016/S0140-6736(17)31628-8:

Schuetz Ph et al., Curr Opin Crit Care 2013;19 (5),Oct: 453-60: Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis; https://www.ncbi.nlm.nih.gov/pubmed/23817026

thermo scientific applied biosystems invitrogen fisher scientific unity lab service